It has been about a month since the last earnings report for Idexx Laboratories (IDXX). Shares have added about 0.5% in that time frame, outperforming the S&P 500. But investors have to be wondering, ...
IDEXX Laboratories IDXX has shown strong momentum in the last 12 months, rising 39.4%. The stock has comfortably surpassed the industry’s 4.3% decline and the S&P 500 Composite’s 23.1% return.
Shares of IDEXX Laboratories Inc. IDXX slipped 1.70% to $608.41 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 1.33% to ...
Idexx Laboratories has steadily increased its scale and reach in the veterinary diagnostic lab business to dig a wide moat. It is well-positioned to benefit from two key trends. First, pet ownership ...
[Audio Gap] on Day 1 of the Raymond James Institutional Investor Conference. I'm Andrew Cooper. I'm happy to be joined here by the team from IDEXX. We've got CEO, Jay. We've got incoming CEO, Mike, ...
On Monday, 02 March 2026, IDEXX Laboratories (NASDAQ:IDXX) shared a strategic update at the 47th Annual Raymond James Institutional Investor Conference. Jay Mazelsky, President and CEO, outlined the ...
IDEXX Laboratories, Inc.’s IDXX focus on innovation in CAG (Companion Animal Group) has resulted in a highly compelling portfolio of products and services for its commercial teams to support customers ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results